Invention Grant
- Patent Title: Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
-
Application No.: US15907422Application Date: 2018-02-28
-
Publication No.: US10881644B2Publication Date: 2021-01-05
- Inventor: Lixiao Wang
- Applicant: Lutonix, Inc.
- Applicant Address: US MN New Hope
- Assignee: Lutonix, Inc.
- Current Assignee: Lutonix, Inc.
- Current Assignee Address: US MN New Hope
- Agency: Dinsmore & Shohl LLP
- Main IPC: A61F13/00
- IPC: A61F13/00 ; A61M31/00 ; A61K31/436 ; A61K31/337 ; A61L31/16 ; A61L29/16 ; A61L29/08 ; A61M25/10 ; A61F2/82 ; A61K9/00 ; A61M16/04

Abstract:
Embodiments of the present invention provide a method for treatment of respiratory disorders such as asthma, chronic obstructive pulmonary disease, and chronic sinusitis, including cystic fibrosis, interstitial fibrosis, chronic bronchitis, emphysema, bronchopulmonary dysplasia and neoplasia. The method involves administration, preferably oral, nasal or pulmonary administration, of anti-inflammatory and anti-proliferative drugs (rapamycin or paclitaxel and their analogues) and an additive.
Public/Granted literature
Information query